Biovotec is excited to announce our innovative, affordable Advanced Wound Care dressing: DermaRep™


DermaRep™ is a wound contact dressing designed to optimise the wound bed in chronic wounds and promote granulation, whilst assisting in the modulation of excess matrix metalloprotease activity that can be associated with chronic wounds.


When applied, DermaRep™ hydrates, it becomes soft and gel-like and is comfortable, conforming to the wound surface.


DermaRep™ is intended for use in conjunction with all other routine care, to optimise the conditions of the wound bed, manage exudate levels and so support healing. It is an adjunctive treatment that is used together with the clinician’s choice of appropriate secondary dressing and routine compression.

DermaRep™ does not need to be removed like other wound contact dressings and therefore does not induce pain on removal.


Biovotec has developed a novel medical device that incorporates Purified Eggshell Membrane Protein, or PEP™.

PEP™ consists of micron-sized protein particles, produced from the lining of domestic chicken eggs, a by-product of the food industry. By tapping into an existing value chain PEP™ can be sourced at a low cost, while maintaining the highest quality and safety standards.


DermaRep™ consists of a dissolvable film device, where PEP™ is evenly distributed within a cellulose and glycerol carrier. Biovotec has optimised the ratio of cellulose, glycerol and PEP™ to provide the highest level of performance.


Pre-clinical studies have shown that PEP™ powder particles alone and specifically when formulated as DermaRep™ optimise the wound healing environment and promotes granulation in chronic wound models.

DermaRep™ assists in maintaining a moist environment at the wound surface and optimises the conditions for wound repair.


Biovotec has completed its First-in-Human trial of DermaRep™ in the UK. We believe that our DermaRep™ device, with PEP™ technology, can bring affordable, advanced wound care to everyone who needs it.